
You can purchase shares of Cardio Diagnostics Hldgs (NASDAQ:CDIO) through any online brokerage.
Other companies in Cardio Diagnostics Hldgs’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Cardio Diagnostics Hldgs has a consensus price target of $60.00.
The stock price for Cardio Diagnostics Hldgs (NASDAQ: CDIO) is $1.73 last updated October 28, 2026 at 6:16 AM EDT.
There are no upcoming dividends for Cardio Diagnostics Hldgs.
Cardio Diagnostics Hldgs does not have any upcoming earnings scheduled.
There is no upcoming split for Cardio Diagnostics Hldgs.
Cardio Diagnostics Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven...